Chief, Cardiovascular Medicine
Cardiology
Dr. Mark I. Furman, MD
|
|
Give Review
Mark Furman practices Cardiology. He graduated from Emory University School of Medicine. Emory University School of Medicine is ranked 23/42 in Research/PrimaryCare. He over the years received 1 awards: "Fellow (FACC)". Dr. Mark I. Furman is also published. He has 31 publications published. The lastest publication: "The influence of intermittent hypoxemia on platelet activation in obese patients with obstructive sleep apnea.'
Publications
- The influence of intermittent hypoxemia on platelet activation in obese patients with obstructive sleep apnea.
- Heparin-associated anti-Xa activity and platelet-derived prothrombotic and proinflammatory biomarkers in moderate to high-risk patients with Acute coronary syndrome.
- Association of cyclooxygenase-1-dependent and -independent platelet function assays with adverse clinical outcomes in aspirin-treated patients presenting for cardiac c...
- Antiplatelet therapy and platelet function testing.
- Clinical considerations with the use of antiplatelet therapy in patients undergoing percutaneous Coronary intervention.
- Investigating the mechanisms of hyporesponse to antiplatelet approaches.
- Antiplatelet strategies: evaluating their current role in the setting of Acute coronary syndromes.
- The problem of persistent platelet activation in Acute coronary syndromes and following percutaneous coronary intervention.
- Assessing the current role of platelet function testing.
- Antiplatelet therapy and platelet function testing. Introduction.
- Translating evidence into practice: are we neglecting the neediest?
- ''Postconditioning'' the human Heart: multiple balloon inflations during primary angioplasty may confer cardioprotection.
- Measuring antiplatelet drug effects in the laboratory.
- Current options in platelet function testing.
- Residual arachidonic acid-induced platelet activation via an adenosine diphosphate-dependent but cyclooxygenase-1- and cyclooxygenase-2-independent pathway: a 700-pati...
- GPIIb/IIIa inhibitor-induced dethrombosis.
- Application of flow cytometry to platelet Disorders.
- The role of platelet inhibition in the drug-eluting stent era.
- Release of soluble CD40L from platelets is regulated by glycoprotein IIb/IIIa and actin polymerization.
- Elevated leukocyte count and adverse hospital events in patients with Acute coronary syndromes: findings from the Global Registry of Acute Coronary Events (GRACE).
- Combined effects of mild hypothermia and glycoprotein IIb/IIIa antagonists on platelet-platelet and leukocyte-platelet aggregation.
- A novel point-of-care enoxaparin monitor for use during percutaneous Coronary intervention. Results of the Evaluating Enoxaparin Clotting Times (ELECT) Study.
- Leukocytosis and adverse hospital outcomes after Acute myocardial infarction.
- Whole blood analysis of leukocyte-platelet aggregates.
- Quantification of abciximab-induced platelet inhibition is assay dependent: a comparative study in patients undergoing percutaneous Coronary intervention.
- The cleaved peptide of PAR1 is a more potent stimulant of platelet-endothelial cell adhesion than is thrombin.
- Activated clotting times in the setting of eptifibatide use during percutaneous Coronary intervention.
- An additional mechanism of action of abciximab: dispersal of newly formed platelet aggregates.
- The Ultegra rapid platelet-function assay: comparison to standard platelet function assays in patients undergoing percutaneous Coronary intervention with abciximab the...
- Immunophenotypic analysis of platelets.
Schools
Emory University
Brigham Womens Hospital
Johns Hopkins Med Institute
Procedures Preformed
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- Cardiac Myocardial Perfusion Imaging
- Cardioverter-Defibrillator or Pacemaker Insertion, Removal or Repair
- View All
Conditions Treated
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Valve Disease
- Arrhythmias (incl. Atrial Fibrillation)
- View All
Doctors Specialties
- Cardiology
- Interventional Cardiology
Accepted Insurances
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- Fallon Community Health Plan
- First Health (Coventry Health Care) PPO
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
Awards
- Fellow (FACC)
Education
-
Johns Hopkins University -
Brigham and Women's Hospital -
Emory University School of Medicine
Hospital
-
Brigham and Women's Hospital -
South Shore Hospital
Helpful Reviews
Similar Doctors
|
|
Dr. Michael J. Hession, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Susan G. Feinstein, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard W. Whitney, MD |
|
|
Dr. Peter A. Grape, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paul J. Schubert, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ronald W. Dunlap, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joseph P. Jiang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Wendy M. Johnson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alexei Shvilkin, MD
This Doctor is OpenDoctor Recommended.
|